Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.

Starting soon

Conditions studied: STEMI, No-Reflow Phenomenon, Diabetic Patient

In brief

To investigate the relationship between the TyG index, coronary lesion complexity assessed by the SYNTAX score, and the development of the no-reflow phenomenon in STEMI patients with T2DM.

Key facts

Study ID

NCT07706335

Run by

Assiut University

People needed

100

Starts

2026-08-01

Expected to finish

2029-08-01

Last updated by the study team

2026-07-16

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18 years
• Type 2 Diabetes Mellitus patients .
• Undergoing PCI for STEMI.
• Written informed consent obtained.

You may not qualify if…

• 1. Individuals with a previous history of myocardial infarction (MI) or decompensated heart failure.
• Individuals with Cardiogenic shock. 3. Individuals with a history of PCI or coronary artery bypass grafting (CABG). 4.Previous familial mixed dyslipidemia / Hypertriglycerideemia (Homozygous or heterozygous).
• Patients with significant hepatic impairment (transaminase levels ≥ 2x normal value).
• Patients with renal impairment (GFR < 60 mL/min/1.73 m²). 7.Active infection or inflammatory disease. 8.Known autoimmune disease. 9.Malignancy. 10. Type 1 Diabetes Mellitus patients.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.